HCN Essentials: COVID-19: Natural Immunity, Antibodies | Vaccine and Pregnancy | Duchenne Muscular DystrophySeptember 22, 2021 | Trending in Healthcare Allergy & Immunology Vaccinating People Who Have Had COVID-19: Why Doesn’t Natural Immunity Count in the US? Nearly a third of all Americans (100 million people) have now been infected with COVID-19. And scientific evidence shows that natural immunity from infection is durable and long-lasting. So why is it then that inoculations continue to be pushed for all people regardless of whether they have contracted COVID-19 or not? And why isn’t natural immunity factored into medical decisions about how we prioritize vaccinations? Read full article Allergy & Immunology Duration of Effective Antibody Levels After COVID-19 Antibodies against COVID-19 continue to perplex and confound physicians and research scientists. Although people who have gotten COVID-19 or been vaccinated against the respiratory disease develop a humoral immune response that protects them from reinfection, those antibodies decline over time, leaving people vulnerable to reinfection. Understanding why this happens is critically important to modeling how COVID-19 spreads through the general population, including children. Read full article Family Medicine/General Practice Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy Publication: JAMAMethod: Electronic health record (EHR) data from 8 health systems over seven 4-week surveillance periods to identify and assign gestational ages for spontaneous abortions and ongoing pregnancies; analyzed and compared odds of receiving a COVID-19 vaccine in the 28 days prior to spontaneous abortion and ongoing pregnancies.Results: Of 105,446 unique pregnancies, 13,160 spontaneous abortions and 92,286 ongoing pregnancies were identified; spontaneous abortions did not have an increased odds of exposure to a COVID-19 vaccination in the prior 28 days compared with ongoing pregnancies. Read full article Internal Medicine Focus on Duchenne Muscular Dystrophy ReachMD offers this CME/video case study on Duchenne Muscular Dystrophy (DMD), new genetic understandings, MET inhibitor use, and presentation with extra muscular manifestations. The program also highlights the challenges healthcare professionals face when it comes to diagnosing this complex condition. Read full article